{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}],"title":"<=-0.25 ng/mL"},{"categories":[{"measurements":[{"groupId":"OG000","value":"84"},{"groupId":"OG001","value":"85"},{"groupId":"OG002","value":"49"}]}],"title":">-0.25-0 ng/mL"},{"categories":[{"measurements":[{"groupId":"OG000","value":"91"},{"groupId":"OG001","value":"90"},{"groupId":"OG002","value":"122"}]}],"title":">0-0.25 ng/mL"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"5"}]}],"title":">0.25-0.5 ng/mL"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}],"title":">0.5 ng/mL"}],"denoms":[{"counts":[{"groupId":"OG000","value":"176"},{"groupId":"OG001","value":"178"},{"groupId":"OG002","value":"179"}],"units":"Participants"}],"description":"Testosterone increases on Day 255 and/or on Day 259 (highest value of Day 255 and Day 259 was used) were compared with Day 252 values. Patients were categorised with shifts of \\<=-0.25, \\>-0.25-0, \\>0-0.25, \\>0.25-0.5 and \\>0.5 ng/mL from mean testosterone levels on Day 252.","groups":[{"description":"Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 160 mg SC (by injection under the skin) given every 28 days.","id":"OG000","title":"Degarelix 240/160 mg"},{"description":"Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 80 mg SC (by injection under the skin) given every 28 days.","id":"OG001","title":"Degarelix 240/80 mg"},{"description":"Lupron Depot 7.5 mg IM (in the muscle) every 28 days starting at day 0.","id":"OG002","title":"Leuprolide 7.5 mg"}],"paramType":"NUMBER","populationDescription":"ITT population who had blood samples drawn on Day 252, Day 255, and Day 259.","reportingStatus":"POSTED","timeFrame":"Day 252, Day 255, and Day 259","title":"Frequency and Size of Testosterone Changes at Day 255 and/or Day 259 Compared to the Testosterone Level at Day 252","type":"SECONDARY","unitOfMeasure":"participants"}